Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Ahn-Gook Pharmaceutical Co Ltd
Other Receivables
Ahn-Gook Pharmaceutical Co Ltd
Other Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
|
Other Receivables
₩1.6B
|
CAGR 3-Years
35%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-7%
|
|
|
Yuhan Corp
KRX:000100
|
Other Receivables
₩19.8B
|
CAGR 3-Years
16%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-1%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Other Receivables
₩13.3B
|
CAGR 3-Years
167%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Other Receivables
₩1.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-13%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Other Receivables
₩9.9B
|
CAGR 3-Years
41%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Other Receivables
₩261m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
Ahn-Gook Pharmaceutical Co Ltd
Glance View
AHN-GOOK PHARMACEUTICAL Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-06-15. The Company’s products include respiratory agents, gastrointestinal agents, anti-inflammatory, analgesic agents, ophthalmic agents and circulatory system agents. The company also provides antibiotic, antifungal drugs, antihyperlipidemic agents, antiallergic drugs, anti-diabetic drugs, urinary system drugs and skin disease remedies. In addition, the Company provides other over the counter (OTC) and ethical (ETC) drugs. The firm distributes its product within domestic market and to overseas markets.
See Also
What is Ahn-Gook Pharmaceutical Co Ltd's Other Receivables?
Other Receivables
1.6B
KRW
Based on the financial report for Dec 31, 2025, Ahn-Gook Pharmaceutical Co Ltd's Other Receivables amounts to 1.6B KRW.
What is Ahn-Gook Pharmaceutical Co Ltd's Other Receivables growth rate?
Other Receivables CAGR 10Y
-7%
Over the last year, the Other Receivables growth was 434%. The average annual Other Receivables growth rates for Ahn-Gook Pharmaceutical Co Ltd have been 35% over the past three years , -20% over the past five years , and -7% over the past ten years .
